How to handle the delayed or the missed dose of edoxaban in patients with non-valvular atrial fibrillation: model-informed remedial strategy [PDF]
, 2021 Yiwei Yin +4 more
openalex +1 more source
Elderly patients with atrial fibrillation in routine clinical practice—peri-procedural management of edoxaban oral anticoagulation therapy is associated with a low risk of bleeding and thromboembolic complications: a subset analysis of the prospective, observational, multinational EMIT-AF study [PDF]
, 2020 Martin Unverdorben +9 more
openalex +1 more source
Extensive deep vein thrombosis treatment using fondaparinux and edoxaban: a case report
, 2016 Kazuhiro Shimizu +3 more
openalex +1 more source
Edoxaban Versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR: The ADAPT-TAVR Randomized Clinical Trial [PDF]
, 2022 Duk‐Woo Park +25 more
openalex +1 more source
Assess the reporting quality of randomized controlled clinical trials exploring the efficacy and safety of new anticoagulants versus warfarin in patients with atrial fibrillation based on CONCORT statement [PDF]
, 2016 Μαντζουράτου, Πολυξένη Δ.
core +1 more source
Effects of DOACs on Mouse Melanoma Metastasis and the Inhibitory Mechanism of Edoxaban, a Factor Xa-Specific DOAC. [PDF]
TH OpenHiramoto K +3 more
europepmc +1 more source
Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention [PDF]
, 2019 Itziar Oyagüez +7 more
openalex +1 more source
Life-threatening pericardial bleed complicating atrial fibrillation ablation associated with edoxaban therapy successfully managed with prothrombin complex concentrate [PDF]
, 2019 Moinuddin Choudhury +2 more
openalex +1 more source
Direct oral anticoagulants in very elderly and high-bleeding-risk patients with atrial fibrillation often excluded from oral anticoagulation therapy: a nationwide population-based cohort study. [PDF]
EuropaceGo YH +7 more
europepmc +1 more source